Kestra Medical Technologies logo

Kestra Medical Technologies

KMTS | NASDAQ
Chart Builder DCF Calculator
$27.97
-$0.67 (-2.34%)
At close: Nov 16, 2026, 4:00 PM ET
$27.97
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.34%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
35.4
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #635/1021 (Top 62%)

Key Statistics

Market Data

Market Cap $1.67B
1D Range
27.64 28.94
52W Range
17.87 31.63

Valuation (TTM)

PE -10.48
PB 7.49
EV/EBITDA -11.80

Valuation (NTM)

Forward PE N/A
Forward PEG -2.38
Price Target $31.00
Loading financial charts...

Profile

Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease th...

Sector Healthcare
Employees 443
IPO Date Mar 6, 2025
Fiscal Year May - April

Latest News

Kestra Announces Publication of ACE-PAS, the Largest Prospective Real-World Wearable Defibrillator Study, in the Journal of Cardiovascular Electrophysiology

20 hours ago · globenewswire.com

Kestra Announces Publication of ACE-PAS, the Largest Prospective Real-World Wearable Defibrillator Study, in the Journal of Cardiovascular Electrophysiology
Kestra Medical Technologies to Participate in Upcoming Investor Conferences

18 days ago · globenewswire.com

Kestra Medical Technologies to Participate in Upcoming Investor Conferences
Kestra Medical: Strong Scaling Story, But Profitability Still On The Horizon

2 months ago · seekingalpha.com

Kestra Medical: Strong Scaling Story, But Profitability Still On The Horizon
Kestra Medical Technologies, Ltd. (KMTS) Q1 2027 Earnings Call Transcript

2 months ago · seekingalpha.com

Kestra Medical Technologies, Ltd. (KMTS) Q1 2027 Earnings Call Transcript
Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss, Tops Revenue Estimates

2 months ago · zacks.com

Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss, Tops Revenue Estimates
Kestra Medical Technologies Q1 Earnings Call Highlights

2 months ago · marketbeat.com

Kestra Medical Technologies Q1 Earnings Call Highlights
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results

2 months ago · globenewswire.com

Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

2 months ago · benzinga.com

Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Kestra Names Daniel Finney Vice President of Research & Development

2 months ago · globenewswire.com

Kestra Names Daniel Finney Vice President of Research & Development
Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for

2 months ago · zacks.com

Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for

Earnings

Next Earnings
Dec 10, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$31.00
Upside
+10.83%
Buy (3)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.